Studies using these models have shown that the affinity of the RBD SARS-CoV-2 to the human ACE2 varies between ACE2 genetic variants suggesting that some people might be genetically protected where others are susceptible to COVID-19 (Lippi et al., 2020; Othman et al., 2020). Here, ACE2 is linked to COVID-19.